Reportedly: AgiBot starts new funding round at about RMB 50 billion valuation
Reported by IT Home · not yet confirmed by the company or a second independent outlet. We update this page when it is.
AgiBot is raising RMB 1–1.5 billion in a new round nearing completion at a valuation of about RMB 50 billion, IT Home reported, citing Caijing. The round means AgiBot cannot complete an IPO this year under HKEX rules.
China context
- Original name
- 智元机器人
- Outside China
- Not stated in the sources yet
- Claims
- Company-reported; not yet independently evaluated
- For builders
- AgiBot's reported production scale and funding may accelerate the availability of low-cost humanoid robot hardware and embodied AI models, but no technical details or outside-China access are confirmed in this evidence.
- For investors
- The reported funding round and IPO delay create a specific timeline risk: AgiBot cannot list on HKEX until at least 120 days after the round closes, which may shift capital to other Chinese robotics companies that can go public sooner.
Translated from Chinese. Quotes and facts link to the original sources.
AgiBot, a general-purpose AI robotics company founded in 2023, has started a new funding round of approximately RMB 1–1.5 billion, which is close to completion, with a latest valuation of about RMB 50 billion, according to a Caijing report cited by IT Home. Under Hong Kong Stock Exchange requirements, a company that completes new financing after filing for listing but before going public must wait 120 days after the financing is completed before it can trade, unless it obtains a special exemption. Investors said the new round means AgiBot will not be able to complete its IPO this year. AgiBot's 20,000th embodied AI robot rolled off the production line on September 24, setting a global mass-production record. According to a Counterpoint Research humanoid robot report, global humanoid robot shipments exceeded 22,000 units in the first half of 2026, up nearly 300% year-on-year. AgiBot ranked first globally with 9,700 units shipped and a market share of over 43%, followed by Unitree, Galbot, UBTECH and Leju Robotics; the top five vendors are all Chinese and together accounted for 86% of total shipments.
The evidence does not describe technical details of the funding round or new product capabilities. The only technical data point is the cumulative production milestone of 20,000 embodied AI robots as of September 24, 2026, and the Counterpoint shipment figures for H1 2026.
AgiBot's new funding round delays its IPO until at least 120 days after the financing closes, which affects investors' exit timeline and may push the listing into 2027. The reported RMB 50 billion valuation and 43% global humanoid robot shipment share in H1 2026 show that Chinese embodied AI companies are consolidating a dominant position in hardware volume.
For investors outside China, the reported valuation of about RMB 50 billion (approx. $7 billion) for a company with 43% global humanoid robot shipment share indicates a high capital intensity and a delayed public-market exit. For competitors, AgiBot's production scale and funding suggest continued price and volume pressure in the humanoid robot market.
The specific signal to watch is whether AgiBot files or updates its Hong Kong listing application after the 120-day waiting period, and whether the reported RMB 1–1.5 billion round is officially announced with named investors. Another checkable signal is whether AgiBot's quarterly shipment share remains above 40% in the next Counterpoint report.